SGHT - sightsciences.com Value Adjusted for Debt and Cash

Graphic logo of Sight Sciences Inc (SGHT)

The Enterprise Value metric for Sight Sciences (SGHT) is 489.41. Business growth is supported by strict FDA oversight and patent protection for the Omni systems. An innovative approach to glaucoma therapy enables the restoration of ocular drainage without the implantation of foreign bodies. The company is currently focusing on surgeon training for its instruments to mitigate regulatory pressure on service costs.

Sight Sciences, Inc - SGHT Total Company Value (period 11/23/2025 - 10/30/2026)

Sight Sciences, Inc. (SGHT) - metric breakdowns and financial figures

- price and consensus price forecast:
Price Rate Chart Sight Sciences Inc.|SGHT - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Sight Sciences, Inc.|SGHT - Real Price to Acquire Entire Company
- book capitalization information:
Book Price of a Share Sight Sciences, Inc.|SGHT - Company Book Value|Market Capitalization to Book Value sightsciences.com|SGHT - Aggregate Company Assets
- company total debt and liquidity indicators:
Aggregate Debt to Equity Sight Sciences, Inc.|SGHT - Long-Term Debt to Capital|Current Liabilities to Capital sightsciences.com|SGHT - Company Aggregate Debts|Debt to Book Value Sight Sciences, Inc.|SGHT - Company Long-Term Debts|Short-Term Debt Volume Sight Sciences, Inc.|Quick Ratio sightsciences.com
- financial results and valuation multiples details:
SGHT - Company Net Income
Summary company analytics:SGHT - Sight Sciences Inc.
Finished products of Sight Sciences, Inc

Sight Sciences, Inc. (SGHT) is developing the high-tech minimally invasive ophthalmology sector in the US, leveraging patent-protected manufacturing facilities for glaucoma therapy instruments. The enterprise value trend reflects the actual acquisition price of the asset via the sum of market capitalization and liabilities minus liquid assets, allowing investors to filter out market volatility and objectively assess the company's fundamental value.

Who Sight Sciences, Inc. competes with

Full Takeover Company Value Boston Scientific Corp|Edwards Lifesciences Corp - Enterprise Value|Value Adjusted for Debt and Cash RMD (ResMed Corporation)|PODD (Insulet Corporation) - Real Price to Acquire Entire Company|ZBH: Aggregate Business Value|Total Company Value CooperCompanies|Invisalign (ALGN) - Company Buyout Price|Total Company Value Globus Medical Corp (GMED)|TMDX: Full Business Value|Enterprise Value ATEC (Alphatec Holdings, Inc.)|artivion.com (AORT) - Total Enterprise Value|Enovis - Enterprise Value|Integra LifeSciences Corp (IART) - Real Price to Acquire Entire Company|ESTA: Enterprise Value|BBNX - Company Buyout Price|IRMD (IRADIMED CORPORATION) - Enterprise Value|Enterprise Value embecta.com|Total Company Value Tandem Diabetes Care, Inc. (TNDM)|Total Company Value AXGN (AxoGen Inc)|Enterprise Value SIBN (SI-BONE Corp)|Company Buyout Price Orthofix Corp (OFIX)|BVS: Real Price to Acquire Entire Company|Full Business Value KIDS|TMCI: Enterprise Value|Total Enterprise Value Blade Air Mobility (SRTA)|CARL (Carlsmed Corp) - Enterprise Value|Business Value RXST (RxSight Ophthalmic)|Real Price to Acquire Entire Company CLPT (ClearPoint Neuro, Inc.)|STXS (stereotaxis.com) - Value Adjusted for Debt and Cash|Total Company Value Neuronetics STIM|OBIO - Real Price to Acquire Entire Company|Anika - Enterprise Value|Total Enterprise Value InspireMD Inc.|ZJYL: Enterprise Value|Business Value VANI|XTNT (Xtant Medical Holdings, Inc.) - Enterprise Value|NeuroOne (NMTC) - Company Buyout Price|Enterprise Value MODD|Real Price to Acquire Entire Company Myomo Inc MYO|Enterprise Value COCH (Envoy Medical, Inc.)|Enterprise Value vivoslife.com VVOS|NVNO - Total Company Value|SINT: Total Company Value|TNON (Tenon Medical, Inc) - Real Price to Acquire Entire Company|Lifeward Ltd. - Value Adjusted for Debt and Cash|AMIX (Autonomix Medical Inc.) - Enterprise Value|Total Enterprise Value invobioscience.com IVF|Total Company Value Bone Biologics Corp (BBLG)|Axonics Inc. (AXNX) - Full Takeover Company Value|Biolase, Inc. - Real Price to Acquire Entire Company|Enterprise Value Dynatronics Corp DYNT|Paragon 28 Corp - Enterprise Value|Company Buyout Price INVO Bioscience, Inc. INVO